相关实验视频
Updated: Sep 11, 2025

08:48
Author Spotlight: Decoding Mitochondrial Aging
Published on: June 30, 2023
4.2K
线粒体疗法 恢复线粒体功能,改善阿尔茨海默病的认知缺陷
Tulika Gupta1, Asha Rao1, Veena Devi1
1Department of Anatomy, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Mitochondrion
|August 17, 2025
概括
线粒体移植改善了阿尔茨海默病患者的认知功能.
科学领域:
- 神经科学是一个神经科学.
- 线粒体生物学 线粒体生物学
- 神经退行性疾病 神经退行性疾病
背景情况:
- 线粒体功能障碍是阿尔茨海默病 (AD) 发病的一个关键因素.
- 这种功能障碍对阿兹海默症患者的认知能力下降有显著的贡献.
研究的目的:
- 为了研究线粒体移植的治疗疗效,以减轻阿尔茨海默病的认知缺陷.
- 评估外源性线粒体对AD相关病理和大脑功能的影响.
主要方法:
- 从结构和功能上验证的线粒体从年轻的老鼠大脑中分离出来.
- 这些线粒体被静脉注射给模拟阿尔茨海默病的老鼠.
- 使用对焦成像来确认标记的线粒体与海马体的整合.
主要成果:
- 线粒体移植导致认知功能显著改善,神经行为测试证实了这一点.
- 移植后观察到粉样蛋白前体蛋白水平显著降低.
- 关键的线粒体功能得到恢复,包括减少氧化应激,增强线粒体膜潜力和正常化的平衡.
结论:
- 线粒体移植 (线粒体疗法) 在阿尔茨海默病中显示出显著的治疗潜力.
- 这种方法有效地改善了认知衰退,并在AD模型中改善了线粒体健康.
- 线粒疗法代表了阿尔茨海默病治疗的有前途的新策略.
相关概念视频
Alzheimer's Disease: Treatment
261
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
261
Mitochondria
14.9K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
14.9K
Electron Transport Chain: Complex I and II
15.0K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
15.0K
Alzheimer's Disease: Overview
668
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
668
Role of Neurotransmitters in Memory
978
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
978
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
206
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
206

